Infliximab weakens COVID-19 antibody response for IBD patientsMarch 24, 2021COVID-19 UpdatesIBD & Intestinal Disorders
Cumulative inflammatory burden predicts cancer risk in ulcerative colitisMarch 22, 2021GI OncologyIBD & Intestinal Disorders
Adalimumab earns FDA approval for ulcerative colitis in childrenMarch 2, 2021IBD & Intestinal Disorders
Vedolizumab looks safer than anti-TNF drugs in older adults with IBDFebruary 11, 2021IBD & Intestinal Disorders
FDA alert confirms heart and cancer risks with tofacitinib (Xeljanz)February 8, 2021IBD & Intestinal Disorders
AGA Clinical Practice Update: Diagnosis and management of immune checkpoint inhibitor enterocolitis and hepatitisFebruary 4, 2021Liver DiseaseIBD & Intestinal Disorders
AGA Clinical Practice Update: Medical management of colonic diverticulitisJanuary 6, 2021IBD & Intestinal Disorders
IBD patients more likely to stick with vedolizumab than anti-TNF drugsJanuary 5, 2021IBD & Intestinal Disorders
